Revolutionizing Transdermal Therapeutics
At 11Three Tech, we are committed to transforming the landscape of transdermal therapeutics through our pioneering SENDS™ technology. Our lead asset, RELIEFTA™, exemplifies our dedication to innovation and excellence in drug delivery systems. By leveraging advanced formulation science and strategic partnerships, we aim to expand our therapeutic pipeline and deliver impactful solutions to patients worldwide. Join us as we pave the way for the next generation of pharmaceutical advancements. https://11threetech.com/products-pipeline/
PL